IDEXX Laboratories Inc
Затворен
СекторЗдравеопазване
508.35 1.06
Преглед
Промяна на цената на акция
24 ч
Минимум
500.03
Максимум
505.26
Приходи | 60M 338M |
|---|---|
Продажби | 76M 1.2B |
P/E Средно за сектора | 37.597 56.597 |
EPS | 4.27 |
Марж на печалбата | 27.817 |
Служители | 11,000 |
EBITDA | 68M 468M |
Следващи печалби | 2.11.2026 г. |
|---|
Пазарна капитализация | -2.6B 42B |
|---|---|
Предишно отваряне | 507.29 |
Предишно затваряне | 508.35 |
Настроения в новините
By Acuity
41%
59%
98 / 339 Класиране в Healthcare
IDEXX Laboratories Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Свързани новини
Сравнение с други в отрасъла
Ценова промяна
IDEXX Laboratories Inc Прогноза
Настроение
By Acuity
98 / 339 Класиране в Здравеопазване
Настроения в новините
Бичи доказателства
Волатилност
Под средното
Обем новини (RCV)
Под средното
Финанси
Продажбени и админисративни разходи
Оперативни разходи
Печалба преди облагане с данъци
Продажби
Разходи за продажби
Брутна печалба от продажби
Разходи за лихви по дълг
EBITDA
Оперативна печалба
$
Относно IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.